米尔纳西普兰对西斯普拉丁诱导的神经病变具有抗高压疗效
Sun Jin Cho1, Jin Young Lee2, Yujin Jeong1
1Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Pharmaceutics
|September 28, 2023
概括
米尔纳西普兰有效地降低了与西斯普拉丁诱导的神经病变的小鼠的疼痛敏感性. 这项研究证实了milnacipran的存在.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛研究 疼痛研究
背景情况:
- 米尔纳西普兰是一种具有已知的 analgesic 特性的血清 - 上腺素再吸收抑制剂.
- 它在西斯普拉丁诱导的神经病痛模型中的有效性以前没有被研究过.
研究的目的:
- 评估内 (IP) 密尔纳西普兰的抗超痛效应,在一只小鼠模型中,对西斯普拉丁诱导的外围神经病变进行评估.
- 评估米尔纳西普兰对背脊根结节 (DRG) 中神经元激活标记物的影响.
主要方法:
- 通过重复注射西斯普拉丁,在小鼠中诱导了外围神经病变.
- 不同剂量的米尔纳西普兰或盐水被用腹膜内注射.
- 在施用后的多个时间点使用·弗雷伊毛发测量了机械体.
- 在DRG中量化了激活转录因子3 (ATF3) 表达.
主要成果:
- 米尔纳西普兰显著扭转了神经病痛特征的脚撤回值的下降.
- 在接受米尔纳西普兰治疗的组中观察到机械体的剂量依赖减弱.
- 米尔纳西普兰的使用导致DRG中神经元ATF3激活的显著减少.
结论:
- 内米尔纳西普兰有效地减轻了机械体在一个小鼠模型的cisplatin诱导的多神经病痛.
- 观察到的止痛效应与背脊根结节中神经元ATF3激活的抑制相关.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
184
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
184
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
231
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
231
Analgesia and Pain Management
649
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
649
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
300
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
300
Nociception
28.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.0K


